List of articles with "UCB"

UCB's Research at AES 2025

UCB's Research at AES 2025

United States Atlanta UCB Epilepsy CDKL5
KYGEVVI® Approval

KYGEVVI® Approval

United States Atlanta UCB TK2d KYGEVVI®
BIMZELX® Long-Term Efficacy

BIMZELX® Long-Term Efficacy

USA Atlanta UCB BIMZELX Hidradenitis Suppurativa
FINTEPLA's Promise in LGS

FINTEPLA's Promise in LGS

United States Atlanta UCB FINTEPLA Lennox-Gastaut Syndrome
BIMZELX® Efficacy

BIMZELX® Efficacy

USA Atlanta UCB Psoriasis BIMZELX
BIMZELX® Three-Year Data

BIMZELX® Three-Year Data

USA Atlanta UCB BIMZELX Hidradenitis Suppurativa
UCB at Epilepsy Congress

UCB at Epilepsy Congress

UCB Brussels Belgium Epilepsy FINTEPLA
UCB at Epilepsy Congress

UCB at Epilepsy Congress

UCB Epilepsy Research Brussels Belgium Dravet Syndrome
UCB HS Summit 2025

UCB HS Summit 2025

USA Atlanta UCB BIMZELX Hidradenitis Suppurativa
Thymidine Kinase 2 Focus

Thymidine Kinase 2 Focus

USA Ann Arbor UCB Genomenon TK2 deficiency
BIMZELX® Awareness Campaign

BIMZELX® Awareness Campaign

UCB BIMZELX Hidradenitis Suppurativa
UCB Phase 3 Results

UCB Phase 3 Results

United States Atlanta UCB CDKL5 fenfluramine
UCB Reveals TK2d Research

UCB Reveals TK2d Research

United States St. Louis UCB Thymidine Kinase UMDF
UCB Expands Biologics Manufacturing

UCB Expands Biologics Manufacturing

United States Manufacturing Atlanta biopharmaceuticals UCB
UCB & Domino Collaboration

UCB & Domino Collaboration

Data Science UCB Brussels Belgium Domino
UCB Neurology Research 2025

UCB Neurology Research 2025

United States San Diego UCB Epilepsy Neurology
TK2d Therapy Breakthrough

TK2d Therapy Breakthrough

UCB Brussels Belgium Thymidine Kinase TK2d
FINTEPLA for Dravet Syndrome

FINTEPLA for Dravet Syndrome

United States Atlanta UCB Dravet Syndrome FINTEPLA
BIMZELX® Breakthrough

BIMZELX® Breakthrough

USA Orlando UCB BIMZELX Hidradenitis Suppurativa
BIMZELX® Efficacy Results

BIMZELX® Efficacy Results

USA Orlando UCB Psoriasis BIMZELX
UCB's Remarkable Growth

UCB's Remarkable Growth

UCB Brussels Belgium FINTEPLA BIMZELX
BIMZELX Single Injection

BIMZELX Single Injection

United States Atlanta UCB BIMZELX bimekizumab
UCB Partners with XtalPi

UCB Partners with XtalPi

USA Cambridge UCB XtalPi XtalFold
UCB Insights on Epilepsy

UCB Insights on Epilepsy

United States Los Angeles UCB Epilepsy FINTEPLA
CBC Group Acquires UCB Portfolio

CBC Group Acquires UCB Portfolio

Singapore UCB CBC Group NeuroGen Pharma
CBC's UCB Acquisition

CBC's UCB Acquisition

Singapore UCB CBC Group Mubadala
UCB at AES 2024

UCB at AES 2024

United States Los Angeles UCB AES 2024 Epilepsy Research

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.